Teresa Amaral: Did you know that so far the data presented at ESMO23 made it to publications in the NEJM
Teresa Amaral, recently tweeted:
“Did you know that so far the data presented at ESMO23 made it to publications in the NEJM!
One of the best congresses so far! This is one of the reasons why you should attend the congress!”
Source: Teresa Amaral/X/Twitter
Teresa Amaral is a Consultant Medical Oncologist and the Head of Skin Cancer Clinical Trials Center at the Tuebingen University Hospital in Germany. Dr Amaral obtained her MD degree from Lisbon University in 2006, concurrent with her degree in Aeronautic Medicine from the Portuguese Air Force. Following her graduation, she pursued her general internship at CHLN and Hospital Pulido Valente in Lisbon in 2007, followed by Medical Oncology Internship in 2008. She is a board-certified Specialist in Medical Oncology since 2014. Between 2020 and 2022, Dr Amaral served as the Chair of the ESMO (European Society for Medical Oncology) Young Oncologists Committee. Currently, she is member of the ESMO Melanoma and Other Skin Tumours Faculty and subject editor for melanoma and other skin cancers guidelines. Since January 2023 she is Chair of the ESMO Leadership Development Committee and serves as an ESMO Council Member.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023